Early loss of glucagon response to hypoglycemia found in teens

Early loss of glucagon response to hypoglycemia found in teens
In adolescents with type 1 diabetes the glucagon response to hypoglycemia is lost as early as one month and at a median of eight months after diabetes diagnosis, according to a study published online June 14 in Diabetes Care.

(HealthDay) -- In adolescents with type 1 diabetes the glucagon response to hypoglycemia is lost as early as one month and at a median of eight months after diabetes diagnosis, according to a study published online June 14 in Diabetes Care.

To investigate the glucagon response to hypoglycemia in adolescents with type 1 diabetes, Aris Siafarikas, M.D., of the Princess Margaret Hospital for Children in Perth, Australia, and colleagues conducted a study involving 28 nonobese adolescents with type 1 diabetes (median duration, 0.66 years) and 12 healthy control subjects.

The researchers found that there was a similar glucagon peak to arginine stimulation between the groups (P = 0.27). In adolescents with type 1 diabetes the glucagon peak to hypoglycemia was statistically significantly lower than in control individuals (68 versus 96 pg/mL). For 7 percent of adolescents with diabetes and 83 percent of controls this response was more than three standard deviations greater from baseline and was lost after a median duration of eight months of diabetes and as early as one month after diagnosis. The response did not correlate with height, weight, , or glycated hemoglobin.

"We conclude that adolescents with type 1 diabetes have impaired glucagon responses to hypoglycemia within 12 months of diagnosis," the authors write. "Prospective studies in children and adolescents starting from the onset of are needed to further characterize the mechanisms influencing the change over time in the response to hypoglycemia."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Study pinpoints role of insulin on glucagon levels

Apr 07, 2009

April 7, 2009 - Researchers at the Joslin Diabetes Center have shown for the first time that insulin plays a key role in suppressing levels of glucagon, a hormone involved in carbohydrate metabolism and regulating blood glucose ...

Recommended for you

Team shows why wound healing is impaired in diabetics

20 hours ago

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.